According to GlobalData, CARPENTIER-EDWARDS PHYSIO is one of 30 product lines sold in the US cardiac valve repair market; these product lines are sold by 5 different manufacturers. The average selling price for CARPENTIER-EDWARDS PHYSIO decreased in hospitals, increased in health systems, and increased outside of hospital facilities in 2022. The price of the CARPENTIER-EDWARDS PHYSIO device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Edwards Lifesciences apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Edwards Lifesciences overview
Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that is engaged in the development, manufacturing and marketing of devices for structural heart disease, critical care and surgical monitoring. The company’s products include surgical valve repair devices, surgical valve replacement, hemodynamic monitoring devices, transcatheter heart valves, pressure monitoring devices, and related instruments and accessories. Its products find application in various therapies, including transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through direct sales force and also a network of independent distributors in North America, Europe and Asia-Pacific, among others. Edwards Lifesciences is headquartered in Irvine, California, the US.
For a complete picture of CARPENTIER-EDWARDS PHYSIO, Cardiac Valve Repair pricing in the US, buy the report here.